Sophia Abene is the Assistant Editor for Contagion. You can email her at abenes@mjhlifesciences.com.
What We Know But Still Have to Learn About Long COVID
Despite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.
Addressing the Diagnostic Gap in Long COVID Care
Clinicians discussed the complexities of diagnosing Long COVID, emphasizing the need for improved biomarkers and diagnostic technologies to better serve affected patients.
Exploring The Challenges and Insights in Long COVID Treatment and Management
Without a specific tailored Long COVID therapy, individualized treatment based on patient phenotypes, along with extensive evaluations, is essential for effective symptom management.
Long COVID’s Impact on the Brain, Specifically Cognitive Function
In our latest roundtable series, experts highlighted research showing that even mild COVID can result in cognitive impairment including brain fog and IQ decline.
Unmasking Long COVID Through Understanding Prevalence and Diagnosis
In our latest roundtable series, experts discussed Long COVID prevalence, underreporting, accurate diagnosis, and emphasized that Long COVID serves as an umbrella term.
Mild COVID-19 Infections Tied to Cognitive and Memory Changes Lasting Over a Year
September 26th 2024A new study revealed that mild infections led to subtle memory and attention deficits lasting at least 12 months, providing further evidence of the complex relationship between COVID-19 and cognitive function.